K
Kim Fox
Researcher at Imperial College London
Publications - 232
Citations - 14837
Kim Fox is an academic researcher from Imperial College London. The author has contributed to research in topics: Coronary artery disease & Myocardial infarction. The author has an hindex of 53, co-authored 221 publications receiving 13841 citations. Previous affiliations of Kim Fox include National Institute for Health Research & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Universal definition of myocardial infarction.
Kristian Thygesen,Joseph S. Alpert,Harvey D. White,Allan S. Jaffe,Fred S. Apple,Marcello Galvani,Hugo A. Katus,L. Kristin Newby,Jan Ravkilde,Bernard R. Chaitman,Peter Clemmensen,Mikael Dellborg,Hanoch Hod,Pekka Porela,Richard Underwood,Jeroen J. Bax,George A. Beller,Robert O. Bonow,Ernst E. van der Wall,Jean-Pierre Bassand,William Wijns,T. Bruce Ferguson,Philippe Gabriel Steg,Barry F. Uretsky,David O. Williams,Paul W. Armstrong,Elliott M. Antman,Keith A.A. Fox,Christian W. Hamm,E. Magnus Ohman,Maarten L. Simoons,Philip A. Poole-Wilson,Enrique P. Gurfinkel,José-Luis López-Sendón,Prem Pais,Shanti Mendis,Jun-Ren Zhu,Lars Wallentin,Francisco Fernández-Avilés,Kim Fox,Alexander Parkhomenko,Silvia G. Priori,Michal Tendera,Liisa-Maria Voipio-Pulkki,Alec Vahanian,A. John Camm,Raffaele De Caterina,Veronica Dean,Kenneth Dickstein,Gerasimos Filippatos,Christian Funck-Brentano,Irene Hellemans,Steen Dalby Kristensen,Keith McGregor,Udo Sechtem,Sigmund Silber,Petr Widimsky,José Luis Zamorano,João Morais,Sorin J. Brener,Robert A. Harrington,David A. Morrow,Michael J. Lim,Marco A. Martinez-Rios,Steve Steinhubl,Glen N. Levine,W. Brian Gibler,David C. Goff,Marco Tubaro,Darek Dudek,Nawwar Al-Attar +70 more
TL;DR: Information on myocardial infarction attack rates can provide useful data regarding the burden of coronary artery disease within and across populations, especially if standardized data are collected in a manner that demonstrates the distinction between incident and recurrent events.
Journal ArticleDOI
Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial.
TL;DR: In patients with stable coronary artery disease and left-ventricular systolic dysfunction, elevated heart rate (70 bpm or greater) identifies those at increased risk of cardiovascular outcomes, with a differential effect on outcomesassociated with heart failure and outcomes associated with coronary events.
Journal ArticleDOI
Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry.
Ph. Gabriel Steg,Ph. Gabriel Steg,Nicola Greenlaw,Jean-Claude Tardif,Michal Tendera,Ian Ford,Stefan Kääb,Hélène Abergel,Hélène Abergel,Kim Fox,Roberto Ferrari +10 more
TL;DR: The risk profiles of women and men with stable CAD differ substantially and further research is needed to better understand gender determinants of outcome and devise strategies to minimize bias in the management and treatment of women.
Journal ArticleDOI
Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial.
TL;DR: The results suggest that ivabradine, representing a novel class of antianginal drugs, is effective and safe during 3 months of use; longer-term safety requires additional assessment.
Journal ArticleDOI
Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials
TL;DR: Results showing these benefits in intermediate-risk patients complement existing evidence of similar benefit in higher- risk patients with LVSD or heart failure and should be considered in all patients with atherosclerosis.